Toronto Dominion Bank raised its position in shares of Core Laboratories N.V. (NYSE:CLB) by 243.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,866 shares of the oil and gas company’s stock after buying an additional 1,323 shares during the quarter. Toronto Dominion Bank’s holdings in Core Laboratories were worth $184,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Parallel Advisors LLC raised its position in shares of Core Laboratories by 13.1% in the 2nd quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock valued at $101,000 after purchasing an additional 117 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Core Laboratories by 63.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 439 shares during the last quarter. Shine Investment Advisory Services Inc. purchased a new position in shares of Core Laboratories in the 2nd quarter valued at approximately $134,000. Advisory Services Network LLC raised its position in shares of Core Laboratories by 33.3% in the 2nd quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock valued at $138,000 after purchasing an additional 341 shares during the last quarter. Finally, First Bank & Trust raised its position in shares of Core Laboratories by 5.8% in the 2nd quarter. First Bank & Trust now owns 1,493 shares of the oil and gas company’s stock valued at $152,000 after purchasing an additional 82 shares during the last quarter.

Several brokerages recently weighed in on CLB. BidaskClub downgraded shares of Core Laboratories from a “sell” rating to a “strong sell” rating in a report on Monday, August 14th. ValuEngine upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Friday, August 4th. Morgan Stanley cut their price target on shares of Core Laboratories from $130.00 to $125.00 and set an “overweight” rating on the stock in a report on Monday, August 7th. Zacks Investment Research downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Finally, Deutsche Bank AG began coverage on shares of Core Laboratories in a report on Tuesday, October 10th. They issued a “buy” rating and a $109.00 price target on the stock. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $108.64.

Shares of Core Laboratories N.V. (NYSE:CLB) opened at $101.57 on Monday. The company has a market cap of $4,480.00, a P/E ratio of 55.50 and a beta of 1.56. Core Laboratories N.V. has a one year low of $86.55 and a one year high of $125.83. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.81 and a current ratio of 2.18.

Core Laboratories (NYSE:CLB) last announced its earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.04. Core Laboratories had a return on equity of 52.89% and a net margin of 12.06%. The firm had revenue of $166.20 million for the quarter, compared to analyst estimates of $160.94 million. During the same quarter last year, the firm posted $0.38 EPS. The business’s revenue was up 1.4% on a year-over-year basis. research analysts forecast that Core Laboratories N.V. will post 1.99 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 21st. Stockholders of record on Friday, October 20th were given a dividend of $0.55 per share. The ex-dividend date of this dividend was Thursday, October 19th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.17%. Core Laboratories’s dividend payout ratio (DPR) is 127.17%.

ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/toronto-dominion-bank-has-184000-holdings-in-core-laboratories-n-v-clb/1728765.html.

About Core Laboratories

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.